Skip to main content
All

Arnold & Porter invites you to this complimentary CLE program for industry professionals. We will provide a brief look back at the key regulatory and enforcement issues impacting the industry in 2021, and offer perspectives on the key challenges, including legislative developments, that we will face in the coming year.

Panels

  • FDA and Related Regulatory Challenges
  • Pricing and Fraud and Abuse Challenges
  • Coverage and Reimbursement Outlook and Developments
  • 2022: Anticipating Legislative and Other Developments

> View the complete agenda.

> View the panelists.

Upcoming Programming: Spring 2022— Life Sciences Regulatory Update (in-person). Click here to ensure you are subscribed to Arnold & Porter's Life Science program information.

Meet the Speakers

Catherine A. Brandon
Partner
Arnold & Porter
Mahnu V. Davar
Partner
Arnold & Porter
Matthew T. Fornataro
Partner
Arnold & Porter
John Gould
Partner
Arnold & Porter
Thomas A. Gustafson, Ph.D.
Senior Policy Advisor*
Arnold & Porter
Abeba Habtemariam
Partner
Arnold & Porter
Jeffrey L. Handwerker
Partner
Arnold & Porter
Kristin M. Hicks
Partner
Arnold & Porter
Ariane M. Horn
Partner
Arnold & Porter
Daniel A. Kracov
Partner
Arnold & Porter
Rosemary Maxwell
Counsel
Arnold & Porter
John McInnes, M.D., J.D.
Counsel
Arnold & Porter
Bobby McMillin, J.D.
Managing Director
Arnold & Porter
Pari R. Mody
Senior Associate
Arnold & Porter
Nancy L. Perkins
Counsel
Arnold & Porter
Eugenia E. Pierson
Senior Health Policy Advisor*
Arnold & Porter
Raqiyyah Pippins
Partner
Arnold & Porter
Allison W. Shuren
Partner
Arnold & Porter
Howard Sklamberg
Partner
Arnold & Porter
Jami Vibbert
Partner
Arnold & Porter